Director/PDMR Shareholding
Updated : 11:07
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Company")
InnovaDerma PLC
Director/PDMR Shareholding
InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty and personal care products, announces, it was notified on 26 February 2019 that Joseph Bayer, Executive Director/Finance Director has purchased 5,000 Ordinary Shares at a price of 86 pence per Ordinary Share (the "Purchase").
Following the Purchase, Joseph Bayer personally now holds a total of 28,180 shares. He also has a separate holding of 93,333 Ordinary Shares held via his Australian Superannuation Fund which Mr Bayer controls. Therefore, Joseph Bayer's total interest in the Company through direct and indirect holdings is 121,513 Ordinary Shares representing approximately 0.84% of the issued share capital of the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma Haris Chaudhry/Joe Bayer |
+61 (0)3 9863 8030 |
finnCap Ltd Geoff Nash/Giles Rolls/Kate Bannatyne Alice Lane - Corporate Broking |
+44 (0)207 220 0500 www.finncap.com |
TB Cardew Shan Shan Willenbrock/Tom Allison Joe McGregor |
+ 44 (0)20 7930 0777
|
1. | Details of the person discharging managerial responsibilities / person closely associated | |
a) | Name | Joseph Bayer
|
2. | Reason for the Notification
| |
a) | Position/status | Executive Director
|
b) | Initial notification/Amendment | Initial notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |
a) | Name | InnovaDerma PLC
|
b) | LEI | 213800WRAP6W8VDL6B38
|
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |
a) | Description of the Financial instrument, type of instrument | €0.10 each ("Ordinary Shares") |
Identification code | IDP GB00BT9PTW34
| |
b) | Nature of the transaction | Purchase of Ordinary Shares
|
c) | Price(s) and volume(s) | Volume and Price - 5,000 Ordinary Shares at 86 pence per share
|
d) | Aggregated information: Aggregated volume Price |
See 4c) above
|
e) | Date of the transaction | 26 February 2019
|
f) | Place of the transaction | London Stock Exchange, Main Market
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.